Nature Biotechnology | Trade Secrets

First Rounders: Jeremy Levin

Jeremy Levin Headshot

The First Rounders discussion with Jeremy Levin can be found here. His family background includes a rather horrific chapter in Lithuania: The Guardian has an informative article discussing this event here. The press release announcing Levin’s hiring at Bristol-Myers Squibb can be found here, and an article on BMS’s changes can be found here. A Forbes article on Teva’s hiring of Levin is at this link, and here’s an interview he did at The Jewish Chronicle after he’d taken the job.

And of course here is Ovid, where Levin is currently CEO. The company closed a $75 million B round in 2015.

Brady Huggett

Comments

There are currently no comments.